{
  "id": "9ae8dbea559a0eb7",
  "title": "Inluriyo / Verzenio Extends Treatment Benefit in ER+ / HER2 \u2013 Breast Cancer",
  "description": "20251212T231500Z",
  "content": "",
  "source": "curetoday.com",
  "source_url": "https://www.curetoday.com/view/inluriyo-verzenio-extends-treatment-benefit-in-er-her2-breast-cancer",
  "published_at": "20251212T231500Z",
  "fetched_at": "2025-12-13T00:21:55.936102+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.curetoday.com/view/inluriyo-verzenio-extends-treatment-benefit-in-er-her2-breast-cancer",
    "url_mobile": "",
    "title": "Inluriyo / Verzenio Extends Treatment Benefit in ER+ / HER2 \u2013 Breast Cancer",
    "seendate": "20251212T231500Z",
    "socialimage": "https://cdn.sanity.io/images/0vv8moc6/curetoday/6f13102c3a84409436f4ab955349da254e18095e-1280x720.jpg",
    "domain": "curetoday.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}